Compounds > methotrexate
Page last updated: 2024-08-25

methotrexate and Syndrome, VKH (Vogt Koyanagi Harada)

methotrexate has been researched along with Syndrome, VKH (Vogt Koyanagi Harada) in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's4 (80.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
de-la-Torre, A; Galindo-Mendez, B; Guayacán, CL1
Du, L; Kijlstra, A; Liang, L; Qi, J; Wang, C; Wu, L; Yang, P; Ye, Z; Zhou, Q1
Acharya, NR; Babu, M; Browne, EN; Kanakath, A; Lee, SM; Porco, TC; Rathinam, SR; Shen, E; Thundikandy, R1
Fukuda, K; Kondo, Y; Nishida, T; Suzuki, K1
Aletaha, M; Dehghan, MH; Peyman, GA; Soheilian, M; Yazdani, S1

Trials

1 trial(s) available for methotrexate and Syndrome, VKH (Vogt Koyanagi Harada)

ArticleYear
Outcomes of Vogt-Koyanagi-Harada Disease: A Subanalysis From a Randomized Clinical Trial of Antimetabolite Therapies.
    American journal of ophthalmology, 2016, Volume: 168

    Topics: Adult; Drug Administration Schedule; Enzyme Inhibitors; Female; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Panuveitis; Uveomeningoencephalitic Syndrome; Visual Acuity

2016

Other Studies

4 other study(ies) available for methotrexate and Syndrome, VKH (Vogt Koyanagi Harada)

ArticleYear
Vogt-Koyanagi-Harada Syndrome in a Group of Patients in Two Ophthalmology Referral Centers in Bogotá, Colombia.
    Ocular immunology and inflammation, 2018, Volume: 26, Issue:7

    Topics: Adult; Colombia; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Methotrexate; Ophthalmology; Referral and Consultation; Retinal Detachment; Retrospective Studies; Uveomeningoencephalitic Syndrome; Vision Disorders; Visual Acuity

2018
Novel treatment regimen of Vogt-Koyanagi-Harada disease with a reduced dose of corticosteroids combined with immunosuppressive agents.
    Current eye research, 2018, Volume: 43, Issue:2

    Topics: Acute Disease; Azathioprine; Cyclophosphamide; Cyclosporine; Drug Therapy, Combination; Fluorescein Angiography; Glucocorticoids; Humans; Immunosuppressive Agents; Methotrexate; Off-Label Use; Prednisone; Recurrence; Retrospective Studies; Treatment Outcome; Uveomeningoencephalitic Syndrome; Visual Acuity

2018
Chronic noninfectious uveitis associated with Vogt-Koyanagi-Harada disease treated with low-dose weekly systemic methotrexate.
    Japanese journal of ophthalmology, 2012, Volume: 56, Issue:1

    Topics: Adult; Chronic Disease; Female; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Treatment Outcome; Uveitis; Uveomeningoencephalitic Syndrome

2012
Management of pediatric Vogt-Koyanagi- Harada (VKH)-associated panuveitis.
    Ocular immunology and inflammation, 2006, Volume: 14, Issue:2

    Topics: Administration, Oral; Adolescent; Cataract; Cataract Extraction; Child; Child, Preschool; Drug Therapy, Combination; Female; Follow-Up Studies; Glaucoma; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Methotrexate; Panuveitis; Prednisolone; Retrospective Studies; Treatment Outcome; Uveomeningoencephalitic Syndrome; Visual Acuity; Vitrectomy

2006